Artificial Intelligence | Machine Learning | Machine Perception Cyclica | Decentralize Drug Discovery
Consumer, Biotechnology, Drug Development, Drug Discovery, Medical Toronto, ON, Canada
Artificial Intelligence | Machine Learning | Machine Perception
Cyclica | Decentralize Drug Discovery
Biotechnology, Drug Development, Drug Discovery, Medical
Toronto, ON, Canada
Cyclica is a biotechnology company that leverages AI and computational biophysics to decentralize drug discovery.
The company approaches polypharmacology with a structure-based, AI-augmented in silico discovery platform, centred on Ligand Design and Ligand Express. Powered by MatchMaker™, a proprietary deep learning proteome screening technology, and POEM™, an innovative supervised learning technology for predicting molecular properties, Cyclica’s platform is suited to the design of novel, drug-like chemical matter by simultaneously prioritizing compounds based on their on- and off-target polypharmacological profiles as well as their developmental properties. With a team that has deep roots in the industry, a platform, and an innovative decentralized partnership model, Cyclica is creating medicines with precision for unmet patient needs.
Jason Mitakidis and Naheed Kurji founded the biotech company in Toronto, Ontario in 2013.
26 to 50
Managed Health Care
Driving Drug Discovery
IT and Security
Natural Language Processing
Cloud Security Operations (SecOps)
Strategic Partnerships Manager
Associate Computational Scientist (Structural Bioinformatics); Ph.D. or M.Sc.